Therefore, the aim of this study was to comprehensively investigate the causal relation for IL-6 or sIL6 with sarcopenia using a two-sample Mendelian randomization approach, and to determine whether targeting these factors may be a viable approach to preventing or treating muscle loss. This evidence concerns the gene IL6 and sarcopenia.